Close menu




September 30th, 2025 | 07:40 CEST

Antimony Resources, Rheinmetall, Novo Nordisk – Something is in the air!

  • Mining
  • antimony
  • Defense
  • Biotechnology
Photo credits: pixabay.com

Sufficient access to raw materials is crucial for any economy. The EU has compiled a list of 34 critical raw materials. How critical a raw material is classified depends on two parameters: "economic importance" and "supply risk." This list also includes a little-known but very important metalloid – antimony. The price of antimony skyrocketed at the end of 2024 in the wake of China's export ban. There are still exciting investment opportunities in this area.

time to read: 2 minutes | Author: Carsten Mainitz
ISIN: ANTIMONY RESOURCES CORP | CA0369271014 , RHEINMETALL AG | DE0007030009 , NOVO NORDISK A/S | DK0062498333

Table of contents:


    Antimony Resources – Still flying under the radar of investors

    Antimony is versatile and in high demand: its applications as a flame retardant, in photovoltaics, defense, semiconductors, and energy storage highlight its importance. As with many other critical metals and rare earths, China dominates global supply. At the end of last year, the country imposed a global export ban. This shines a spotlight on future producers, such as Antimony Resources.

    The Canadians have the option to acquire the Bald Hill property in southern New Brunswick, Canada. Previous drilling has identified antimony over a length of more than 700 m and a depth of 400 m with an average thickness of over 3 m and a grade of 3% to 4% antimony (Sb). This distinguishes Bald Hill as a first-class, high-grade antimony deposit.

    The current drilling program, which could give the stock a significant boost, is divided into several phases. A total of at least 6,000 meters of drilling is to be completed. Phase 1 at Bald Hill has already delivered good results. Significant high-grade antimony deposits were intersected in over 75% of the drill holes. The previously defined main mineralization zone was also significantly expanded.

    The Company has now announced the start of the second phase of its drilling program, with two main priorities. The first is to extend the known antimony-bearing mineralization to the north and south and to expand the mineralization at depth. This trend has already been successfully demonstrated in Phase 1.

    The second priority is to drill at locations that demonstrate a connection between widely separated mineralization zones. The aim is to determine whether the mineralization is sufficiently continuous and whether sufficient data is available.

    Rheinmetall – Above the EUR 2000 mark for the first time

    As mentioned above, antimony plays an important role in the defense industry. This semi-metal increases the hardness and stability of lead and is therefore essential in the manufacture of ammunition and armor. Antimony is also used in high-tech weapons, night vision devices, and infrared sensors.

    German defense stocks continued their rally at the beginning of the week, reaching new all-time highs. Rheinmetall shares climbed slightly above the EUR 2,000 mark for the first time. Although the shares have already increased twentyfold since the start of the war in Ukraine, analysts at UBS and mwb research still see room for growth up to EUR 2,500.

    The enormous demand for weapon systems and ammunition continues to swell order books. The DAX-listed company recently announced that it would be supplying ammunition to Eastern Europe as a subcontractor to a company commissioned by the US government. The total value of the order is in the mid three-digit million range.

    Novo Nordisk – Negative analyst opinion weighs on the stock in the short term

    A significant downgrade by Morgan Stanley to "Underweight", coupled with a price target capped at EUR 40, weighed on the stock in the short term. Analysts expect minimal growth in revenue and profits next year and point to the Danish company's challenging competitive position.

    The shares are currently trading at around EUR 47 and have already priced in many negative factors. At first glance, the stock appears undervalued historically, but growth remains subdued. Investors are not missing out on anything yet and can monitor developments from the sidelines.


    If Antimony Resources' current drilling program proves successful, as initial data suggests, this could give the share price a significant boost. The market capitalization is just CAD 11 million. Rheinmetall is benefiting from sustained high demand and still has room for growth despite reaching an all-time high. A lot of negative factors are already priced into Novo Nordisk's share price.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Carsten Mainitz

    The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research.

    About the author



    Related comments:

    Commented by Fabian Lorenz on September 22nd, 2026 | 07:45 CEST

    Analysts See Multibagger Potential: Nordex, Evotec and Aspermont

    • Digitization
    • bigdata
    • Biotechnology
    • Biotech
    • Technology

    Analysts see multibagger potential in Aspermont's stock. The Australian company appears to be making good progress in its transformation from a specialist publisher into a scalable provider of data and analytics for the global resources industry. The stock has yet to take off. Its 2028 P/E ratio is below 10. Nordex is no longer a bargain. Analysts see further growth opportunities, but the stock has already priced in much of that potential. Nevertheless, analysts recommend buying the shares. The US business is becoming increasingly important. Buying Evotec shares is not an obvious choice right now. The stock has fallen below EUR 3, while positive company news is being ignored by the market. Could this perhaps be an opportunity?

    Read

    Commented by Matthias Schomber on September 22nd, 2026 | 07:25 CEST

    Puma at Rock Bottom, Novo Nordisk Riding the Weight-Loss Boom and Volatus Aerospace in Rebound Mode: Who Is the High-Flyer?

    • Drones
    • Defense
    • hightech
    • Biotechnology
    • weightloss
    • Sportswear

    Broadly speaking, the stock market in Germany, as well as across Europe and globally, is currently under considerable pressure. Two wars in Iran and Ukraine, along with discontent in Germany with the current government, are weighing on markets. In other words, the stock market is under significant strain. The major indices are at or near critical technical levels. Puma, for example, is struggling with margins, while analyst price-target cuts and an upcoming change in the company's head of sales are adding pressure. Novo Nordisk, meanwhile, is facing regulatory headwinds and increasing competition in the US despite rapidly growing future markets in the obesity segment. Volatus Aerospace, by contrast, is raising hopes of a rebound with new government contracts for tactical reconnaissance drones. A technical breakout could make the stock an interesting candidate for strong performance. Read on to learn why Puma still requires plenty of patience, which billion-dollar investments are supporting Novo Nordisk's pipeline, and how investors could potentially take advantage of an entry opportunity in Volatus now.

    Read

    Commented by André Will-Laudien on September 22nd, 2026 | 07:20 CEST

    Tanks, Ships, and Ammunition: How Rheinmetall, Renk, thyssenkrupp, TKMS and Power Metallic Mines Can Make Your Portfolio Bulletproof

    • PGMs
    • Copper
    • Commodities
    • Defense
    • geopolitics

    Geopolitical upheavals are throwing global markets into turmoil and forcing investors to rethink their strategies. It is becoming increasingly clear: The European defence industry is heading toward a massive wave of market consolidation. However, disillusionment is setting in among the defence industry's former high-flyers following the initial hype, as the internal work required for integration is far from complete and operational potential has been overestimated. Completely detached from this trend is the Essen-based maritime division, which has secured a front-row seat thanks to a government deal worth billions. A massive fleet order is injecting a whole new dynamic into the sector. Naturally, strategic raw materials are also taking centre stage, since without them, not a single tank can roll, or a single ship can be launched. In this segment, the wheat is currently being separated from the chaff, as concrete facts and proven reserves far outpace utopian dreams of the future. Investors who want to profit from this tension and build a crisis-proof portfolio must now spread their risks extremely wisely across the globe.

    Read